News
🇺🇸 FDA Page 61Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 721–732 of 807 articles
FDA Approves Elahere: Expanded Use for Platinum-Resistant Ovarian Cancer
FDA · Ovarian Cancer · 4 min
Dr. Sarah MitchellFDA Approves CardioShield: First Drug for HFpEF Treatment
FDA · Heart Failure · 5 min
Dr. Sarah MitchellFDA Approves VitaCorp Antibiotic: Breakthrough for Multi-Drug Resistant Infections
FDA · Infectious Diseases · 7 min
Dr. Sarah MitchellFDA Approves NeuroVance XR: New Pediatric ADHD Extended-Release Option
FDA · Attention Deficit Hyperactivity Disorder (ADHD) · 6 min
Dr. Sarah MitchellFDA Approves LumaGen Gene Therapy for Inherited Retinal Disease
FDA · Inherited Retinal Disease · 8 min
Dr. Sarah MitchellFDA Approves Biosimilar Insulin Lispro: What You Need to Know
FDA · Diabetes Mellitus · 4 min
Dr. Sarah MitchellFDA Approval TRK Inhibitor: OncoCure's Breakthrough for NTRK Tumors
FDA · Oncology · 4 min
Dr. Sarah MitchellFDA Blockchain Pilot Program: Enhancing Pharmaceutical Supply Chain Security
FDA · pharmaceutical supply chain security · 3 min
Dr. Sarah MitchellFDA to Launch AI-Powered Drug Review System by 2027
FDA · serious and life-threatening conditions · 7 min
Dr. Sarah MitchellFDA Approves RenoProtect: New Therapy to Slow Diabetic Kidney Disease
FDA · Diabetic Kidney Disease · 6 min
Dr. Sarah MitchellFDA Approves AirFlow: New Inhalable Treatment for Severe Asthma
FDA · Severe asthma · 6 min
Dr. Sarah MitchellFDA Approves OsteoBuild: New Bone-Building Agent for Severe Osteoporosis
FDA · Osteoporosis · 5 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways